No black box warning on record for Tevimbra
As of the latest FDA labeling reviewed, Tevimbra (TISLELIZUMAB-JSGR) does not carry a black box warning. Standard warnings and precautions still apply — see the full Tevimbra medicine page for the complete safety profile.